Search Results
Results found for "GPCR Therapeutics"
- How System-Level GPCR Thinking Prevents Discovery Failures
Upcoming events:  Adhesion GPCR Workshop; GRC—Transporters, Ion Channels & GPCRs; MPGPCR Joint Satellite GPCR Podcast: Chemical Probes for GPCR Imaging with Dr. GPCR Premium Membership Gives You an Edge Premium gives GPCR scientists and biotech teams a single, trusted GPCR and the offered resources in my work sphere." GPCR research and education across the global community.
- Inside the New Dr. GPCR Ecosystem: Learning, Insight, and Momentum for 2026
Must-read publications:  GPCRs in neurological disorders; OSTα-OSTβ structure; GPCR–G protein–β-arrestin GPCR Podcast—GPCR Assay Strategy, Bias, and Translational Drug Discovery In this episode of the Dr. GPCR podcast , Dr. GPCR innovation is accelerating. GPCR Team
- Your GPCR Program Decisions Depend on Good Data Interpretation
Welcome GPCR Fans,  In GPCR-targeted drug discovery, precision isn’t optional—it’s a requirement. GPCR Premium Members this week gain curated, early access to: Industry insights : GPCRs and mRNA in drug discovery; new strategies for inflammatory disease treatment; growth strategies from Tectonic Therapeutics GPCR Premium Membership Gives You an Edge Dr. GPCR Premium gives you an edge in a fast-moving field.
- Allosteric Binding Demystified: Smarter GPCR Drug Discovery
Hello GPCR Enthusiasts, Interpreting binding data isn’t optional—it’s career-defining. Breakthroughs this week: Decoding ADGRE5 signaling; Eli Lilly’s obesity pill vs Novo’s Wegovy; Certa Therapeutics Read the article now ➤ Discovery on Target - The Next Wave of GPCR Drug Discovery The 20th Annual GPCR-Based GPCR Premium Membership Gives You an Edge The GPCR field is advancing at breakneck speed. The pace of GPCR innovation is accelerating.
- GPCR Allosteric Modulation: Why Allostery is the Engine of Drug Discovery
s latest lecture delivers high-impact insight crafted for teams navigating the complex behaviors of GPCR-targeting As Kenakin explains, all GPCR signaling is allosteric , and pretending otherwise introduces risk at every If you’re still treating GPCRs as passive targets, your screening filters may be blind to key liabilities But without understanding how GPCR state changes  influence that affinity—or vice versa—drug discovery Corner  is your trusted, expert-led guide through the evolving landscape of GPCR science.
- How GPCR Spatial Signaling Sparked a Scientific Journey
For innovators building tools, platforms, or therapeutics, these origin moments are where tomorrow’s receptors control localised signaling, how disease hijacks these systems, and how to target them for therapeutic Her work sits at the intersection of fundamental biology and therapeutic strategy. Knowing where  signals occur could unlock new therapeutic strategies, better efficacy, and fewer side GPCR Podcast 🔓 Want to go deeper? Join  Dr.
- GPCR Internalization: When the Signal Moves Inside the Cell
The Cell Surface Is Only Part of the Story For decades, GPCR pharmacology centered on events at the cell Work on receptors such as GLP-1R and MC4R has demonstrated that internalized GPCRs can continue to signal the cell depends on the ligand–receptor complex — and that distinction has direct implications for therapeutic Recycling Versus Degradation: The CCR5 Example The therapeutic stakes of this distinction are illustrated distinctions, and the interpretive frameworks that connect trafficking data to therapeutic decisions
- From Switches to Microcircuits: GPCR Biased Signaling and the Future of Drug Discovery
Ligands designed to activate therapeutically beneficial pathways, while avoiding those associated with The therapeutic logic is sound: if signaling pathways are separable, they are potentially selectable. as new therapeutic targets. both been implicated in COVID-19 pathophysiology — and represent active targets for receptor-directed therapeutic provides the needed mechanistic depth to define the functional selectivity  that may ultimately determine therapeutic
- Why Kinetics Matter More Than Kd in GPCR Drug Discovery
Welcome GPCR Fans,  Every discovery-phase decision you make shapes your entire pipeline trajectory—and Upcoming events:  5th MMCS New Trends in Drug Discovery; GPCR-UK Network Meeting; neuroGPCR Symposium Must-read publications:  GPCRchimeraDB: Database of engineered GPCR designs. GPCR University Course Attendee Dr. The pace of GPCR innovation is accelerating.
- Assay Volume Control: Your GPCR Drug Discovery Power Lever
Enhance your GPCR research with deeper assay insights for more effective results. This Week’s GPCR Intelligence: If you want cleaner decisions, start with the system—then the ligand. Breakthroughs this week: C. elegans avoids EGCG via SRXA-7 GPCR; a bidirectional GPCR switch modulates allosteric site on an orphan GPCR. 🔍 This Week in Dr. GPCR innovation is accelerating.
- đź“° GPCR Weekly News, June 24 to 30, 2024
We have gathered 24 new research papers on GPCRs and updates on industry news related to GPCRs. Bryan Roth and Brian Krumm for their study on Molecular glues as potential GPCR therapeutics Drs. breast cancer progression by suppressing the MMP8-mediated antitumorigenic effects GPR56: A potential therapeutic GPCR therapeutics A high-affinity, cis-on photoswitchable beta blocker to optically control β2-adrenergic GPCR Ecosystem
- Enzyme Inhibition Pharmacology: The Hidden Gatekeepers of GPCR Drug Discovery
Before your GPCR ligand ever meets its receptor, it meets the enzymes that determine whether it survives Even the most elegant GPCR ligand can fail if it never reaches its receptor. These nuances define therapeutic potential and side-effect risk. Each mode reshapes both potency and therapeutic window. Kenakin with your own enzyme or GPCR interaction puzzles.
- From Failed Experiments to Predictive GPCR Models
Watch Episode 175 From failed assays to breakthroughs in GPCR modeling , Dr. At that point, very few GPCR crystal structures had been determined. For Carlsson, this marked a shift in how his lab approached GPCR research. He came to see that effective GPCR research requires true interdisciplinary integration. those who can unite modeling with experimentation, turning predictions into real therapeutic breakthroughs
- Dr. Josephine (Pina) Cardarelli - Dr. GPCR Podcast
GPCR Podcast, we have Dr. Pina Cardarelli, CSO of GPCR Therapeutics. ecosystem.drgpcr.com/dr-gpcr-podcast/ #gpcr#drgpcr #podcast
- How Breakthroughs Happen: Eric Trinquet on Innovation, Serendipity & GPCRs
Eric Trinquet, a veteran innovator behind functional GPCR assays like HTRF and IP-One, believes rigid If you’re building tools or careers in GPCR science, this is your playbook. It began with an unmet need: how to track Gq-coupled GPCR activity without the mess of calcium flux or GPCR  Dr. GPCR X Revvity Collaboration ⸻ Want more like this? 👉 Join the Dr. GPCR Premium Ecosystem  for behind-the-scenes access to GPCR innovators, exclusive deep-dives, and practical
- How Schild Analysis Protects Your Conclusions in GPCR Research
Listen to the episode ➤ Quick Links Assess GPCR Biased Signaling of Agonist How GPCR Collaboration Built an Innovation Engine From Pipettes to Platforms: The Evolution of GPCR Research How GPCR Spatial Signaling GPCR Premium Membership Gives You an Edge Premium delivers a clear, noise-free stream of GPCR intelligence GPCR innovation is accelerating. GPCR Team
- How a Failed Med School Dream Sparked a GPCR Biotech Revolution
But for Ajay Yekkirala, that closed door lit the fuse for a career that would reimagine GPCR therapeutics therapeutics. therapeutics. Blue Therapeutics: Turning GPCR Biology Into a Business Ajay’s academic training planted the seeds for therapeutics.
- Dr. GPCR Spotlights Revvity’s pHSense™ Internalization Tools
GPCR , the global nonprofit platform dedicated to advancing GPCR science through education, community GPCR Ecosystem. GPCR Podcast To mark the spotlight, Dr. GPCR  invited Dr. Eric Trinquet  to the Dr. GPCR. GPCR Dr.
- đź“° GPCR Weekly News, October 2 to 8, 2023
Hello GPCR people! Check out our GPCR roundup now, and be the first to read! This week's highlight: Congrats to our partner GPCR Therapeutics, on their expansion into fibrosis with selectivity Industry News Sosei Heptares and Verily Nominate First G-protein-coupled receptor Target for Therapeutic Therapeutics Expands Pipeline into Fibrosis with a Combination Approach Targeting LPA1 GPCR Events, GPCR Ecosystem
- GPCR Selectivity Beyond the Receptor — Live April 9th with Bryan Roth
GPCR community live this week to examine what happens when GPCR selectivity is encoded not at the receptor GPCR University iPSC-Derived Systems for GPCR Signaling and Translation HEK293 systems are powerful tools interactions — and with it, how we think about drug discovery at GPCRs. proteome binding dataset enabling AI-driven drug discovery Membrane proteins represent more than half of therapeutic GPCR Dr. GPCR is the intelligence and community platform for GPCR scientists.
- A Note from Yamina: Building the Next Chapter of Dr. GPCR
GPCR. Dear Dr. GPCR, it was with a simple goal: to connect people who shared a passion for GPCR science and discovery GPCR Foundry  — our R&D and biotech hub designed to bridge GPCR science with execution. The Dr. GPCR resources, connect new scientists, and earn rewards  for helping expand access to GPCR knowledge GPCR About Dr. GPCR Dr.
- Beyond HEK293 — Terry Hébert on iPSC-Derived GPCR Models, Live April 16,
April 29, and the GPCRs Drug Discovery Summit April 28-30. iPSC-Derived GPCR Models: Beyond HEK293 for GPCR at the GPCRs Targeted Drug Discovery Summit — Boston, April 28-30 The GPCRs Targeted Drug Discovery Summit brings together scientists working at the intersection of GPCR biology and therapeutic development GPCR University Learner About Dr. GPCR Dr. GPCR is the intelligence and community platform for GPCR scientists.
- đź“° GPCR Weekly News, October 23 to 29, 2023
Hi there GPCR minds! Join us for a deep dive into the world of GPCRs. This week's highlight: Congratulations to the GPCR Therapeutics team for their publication on improving GPCR Symposium for the year on GPCRs in Immunology and Oncology! Therapeutics Announces Publication on Improving Hematopoietic Stem Cell Mobilization Using Propranolol Progress Parker Moss to Join Exscientia as EVP, Corporate Development Confo Therapeutics Nominated for
- How Collaboration Sparked a GPCR Imaging Breakthrough in Chemical Biology
partnership built on trust and curiosity — reshaped both careers and helped unlock a new generation of GPCR How a Collaboration Led to a GPCR Imaging Breakthrough JB didn’t set out to contribute to a GPCR imaging It was the start of a scientific partnership with the potential to shift how GPCRs could be visualized How Chemical Probes Transformed GPCR Imaging and Outperformed Antibodies As JB continued exploring the Designing Reliable GPCR Imaging Tools for Real Biological Systems Success brought new challenges.
- Is Your GPCR Drug Discovery Program Built for Breakthroughs or Breakdowns?
In the high-stakes world of GPCR drug discovery , breakthrough science isn't enough. GPCR, we recognized this core problem. This is the essence of de-risking GPCR programs through operational excellence. the entire GPCR program as a single, interconnected entity. The GPCR Precision Blueprint is more than a concept.
- Accelerating GPCR Drug Discovery: What 40 Years of Pharmacology Reveal
Why Speed Matters in GPCR Drug Discovery Nine out of ten GPCR programs stall  not because the target In accelerating GPCR drug discovery, the bottleneck isn’t target identification — it’s turning validated “GPCRs are nature’s prototype allosteric proteins. Everything they do is allosteric.” Antibodies, Bias, and the Expanding Modality Landscape Antibody therapeutics are now entering spaces Kenakin with your own enzyme or GPCR interaction puzzles.
- When the Islet Lit Up: Advancing GPCR Imaging in Native Tissue
A single successful GPCR imaging experiment can transform a project’s trajectory. Interdisciplinary design isn’t optional in GPCR imaging. It’s the catalyst. And the most striking validation came from in vivo GPCR imaging. Strong GPCR imaging tools come from strong interdisciplinary relationships.  🎧 Listen to the full episode https://www.ecosystem.drgpcr.com/dr-gpcr-podcast/chemical-probes-for-gpcr-imaging-and-internalization
- Posttranslational modifications in GPCR internalization
August 2022 "G protein-coupled receptors (GPCRs) are the largest family of membrane receptors that serve Classically, GPCR internalization has been considered to lead to receptor desensitization. Here, this review summarizes different PTMs in GPCR internalization and analyzes their significance in , which will offer new insights into the regulatory mechanism of GPCR signaling and novel drug targets Read more at the source #DrGPCR #GPCR #IndustryNews
- Competitive vs Non-Competitive GPCR Antagonists: How to Interpret Pharmacology Data with Confidence
Strategies for Targeted Therapeutics. GPCR-Based Drug Discovery conference is where the future of GPCR therapies will be defined. GPCR Premium Membership Gives You an Edge In a world filled with noise, Dr. GPCR Premium Membership delivers curated, noise-free intelligence every week. The pace of GPCR innovation is accelerating.
- How a Failed Experiment Created a Powerful GPCR Imaging Tool
Broichhagen aka JB, the goal was bold and elegant: Create a photo-switchable ligand to remotely control GPCR They had a tool that did bind the GPCR… but not in the light-controlled way they wanted. not just the pancreas This tool helped clarify: Which neurons respond Which cell populations drive therapeutic The Larger Lesson for Scientists and Innovators This story isn’t just about a GPCR imaging tool. metabolic therapy Guide how next-generation incretin drugs are designed Support cell-targeted conjugate therapeutic



























